Medicine Matters diabetes
Medicine Matters diabetes
  • Видео 144
  • Просмотров 213 338

Видео

Initiating GLP-1 receptor agonists: Managing side effects | Nicola Milne
Просмотров 3,7 тыс.2 года назад
Specialist nurse Nicola Milne discusses the side effects that can arise in people with type 2 diabetes during initiation of GLP-1 receptor agonists, and how to best manage them (7:12). View more on Medicine Matters diabetes: diabetes.medicinematters.com/glp-1-receptor-agonists/18817774 and remember to Like this video and Subscribe to our channel
SURMOUNT-1: Heralding a ‘golden age’ for obesity treatment | Louis Aronne
Просмотров 2,4 тыс.2 года назад
Louis Aronne discusses the results of SURMOUNT-1, and why he believes they may represent the start of a major shift in the treatment of people with obesity. View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel
Ramadan fasting, feasts, and type 2 diabetes | Shehla Shaikh
Просмотров 4482 года назад
Shehla Shaikh shares her experience and offers practical advice to help people with type 2 diabetes safely navigate the fasting and feasting of Ramadan. 0:00 Introduction 1:34 Complications: preparation and risk stratification 4:43 Moral authority and shared decision-making 7:37 Leveraging family and social media for support and education 9:26 Coping with Ramadan feasts 14:05 Managing medicatio...
Ramadan and type 1 diabetes: Supporting religious fasting | Simon Heller and Shehla Shaikh
Просмотров 6502 года назад
Simon Heller from the UK talks to Shehla Shaikh from India to learn from her wealth of experience in supporting people with type 1 diabetes to fast during Ramadan. 0:00 Introduction 0:50 Fasting and feasting: The challenges of Ramadan 6:38 Risk stratification and navigating patient wishes 9:37 Insulin and individualization 16:48 Coping with hypoglycemia 18:54 About online resources 19:45 Take-h...
Addressing the challenges of Ramadan for people with diabetes | Sanjay Kalra
Просмотров 2212 года назад
Sanjay Kalra explains why it is so important for healthcare professionals anywhere in the world to understand about Ramadan and the ramifications for people with diabetes. View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel
Why type 2 diabetes is so challenging to manage in children | Phil Zeitler
Просмотров 1322 года назад
Phil Zeitler discusses the pathophysiology of type 2 diabetes in children, and why it is so resistant to conventional management (2:58).
Treatment priorities in children with type 2 diabetes | Julian Hamilton-Shield
Просмотров 1242 года назад
Julian Hamilton-Shield explains why weight loss is the key to type 2 diabetes management in children (2:04)
When to screen for type 2 diabetes in children | AG Unnikrishnan
Просмотров 802 года назад
AG Unnikrishnan highlights the problem of underdiagnosis of type 2 diabetes in children, and explains who to prioritize for screening.
EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors
Просмотров 2,2 тыс.2 года назад
Adriaan Voors discusses the EMPULSE trial of empagliflozin given just after stabilization of de novo or decompensated chronic heart failure (5:21). View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel.
What is hypoglycemia-associated autonomic failure? | Sambit Das
Просмотров 1,2 тыс.2 года назад
Sambit Das gives the highlights of his ESICON presentation on the etiology and management of hypoglycemia-associated autonomic failure (8:12). View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel
PRESERVED-HF: Support for dapagliflozin to improve HFpEF health status | Mikhail Kosiborod
Просмотров 1 тыс.2 года назад
Mikhail Kosiborod outlines the findings from the PRESERVED-HF trial, demonstrating that dapagliflozin improves symptoms and physical function in people with heart failure with preserved ejection fraction, and discusses the promise of SGLT2 inhibitors for meeting the treatment goals in this population (9:35). 00:00 Introduction 02:12 Key findings from PRESEVED-HF 04:42 How dapagliflozin compares...
SAFES summit 2021: Using modern sulfonylureas | Mohammad Wali Naseri
Просмотров 1232 года назад
Mohammad Wali Naseri outlines best practice for use of modern sulfonylureas in people with type 2 diabetes, as presented at the 2021 South Asian Federation for Endocrine Societies summit (5:53). View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel.
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
Просмотров 9472 года назад
Cardiologist Lars Rydén, endocrinologist Alice Cheng, and family physician Kevin Saunders discuss the diagnosis and management of people with type 2 diabetes and shortness of breath in primary care, and how the positive findings of EMPEROR-Preserved will now shape the care of these patients in this webinar. View more on Medicine Matters diabetes: bit.ly/MMd_HFpEF and remember to Like this video...
SURPASS-4: Tirzepatide as an alternative to insulin glargine in type 2 diabetes | Stefano Del Prato
Просмотров 1,3 тыс.2 года назад
Stefano Del Prato discusses the advantages of tirzepatide over insulin glargine for people with type 2 diabetes, and how the SURPASS-4 findings fit with those of the rest of the clinical trial program. View more on on the SURPASS trials on Medicine Matters diabetes: bit.ly/SURPASS-trials and remember to Like this video and Subscribe to our channel
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
Просмотров 542 года назад
Time to reconsider the person with shortness of breath: EMPEROR-Preserved
The ADA/EASD type 1 diabetes consensus: Comprehensive and up to date | Parth Narendran
Просмотров 1852 года назад
The ADA/EASD type 1 diabetes consensus: Comprehensive and up to date | Parth Narendran
How will the TriMaster results impact patient-centered care? | Pinar Topsever
Просмотров 1153 года назад
How will the TriMaster results impact patient-centered care? | Pinar Topsever
Management of type 1 diabetes: ADA/EASD consensus report | Anne Peters
Просмотров 5553 года назад
Management of type 1 diabetes: ADA/EASD consensus report | Anne Peters
The HARPdoc intervention for people with poor hypoglycemia awareness | Stephanie Amiel
Просмотров 1753 года назад
The HARPdoc intervention for people with poor hypoglycemia awareness | Stephanie Amiel
The TriMaster study of individualized medicine in type 2 diabetes | Andrew Hattersley
Просмотров 4043 года назад
The TriMaster study of individualized medicine in type 2 diabetes | Andrew Hattersley
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
Просмотров 6 тыс.3 года назад
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
Просмотров 6 тыс.3 года назад
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy | Stefan Anker
Просмотров 1,9 тыс.3 года назад
EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy | Stefan Anker
EMPEROR-Preserved: The implications for primary care | Kevin Fernando
Просмотров 1,2 тыс.3 года назад
EMPEROR-Preserved: The implications for primary care | Kevin Fernando
A Collaborative Community to address suicide risk in diabetes | Katharine Barnard-Kelly
Просмотров 2603 года назад
A Collaborative Community to address suicide risk in diabetes | Katharine Barnard-Kelly
An update on COVID-19 and diabetes | Stefan Bornstein
Просмотров 3713 года назад
An update on COVID-19 and diabetes | Stefan Bornstein
ADA 2021 - What do the GRADE results mean for clinical practice? | Patrick Holmes
Просмотров 7513 года назад
ADA 2021 - What do the GRADE results mean for clinical practice? | Patrick Holmes
ADA 2021 - The SURPASS trials so far: Tirzepatide, semaglutide, and type 2 diabetes | John Wilding
Просмотров 4,9 тыс.3 года назад
ADA 2021 - The SURPASS trials so far: Tirzepatide, semaglutide, and type 2 diabetes | John Wilding
ADA 2021- SURPASS-5: Tirzepatide in people with insulin-dependent type 2 diabetes | Michelle Welch
Просмотров 2 тыс.3 года назад
ADA 2021- SURPASS-5: Tirzepatide in people with insulin-dependent type 2 diabetes | Michelle Welch